Ethanol extract of Schisandrae chinensis fructus ameliorates the extent of experimentally induced atherosclerosis in rats by increasing antioxidant capacity and improving endothelial dysfunction

References

• Alexander JS, Wang Y. 2012. Therapeutic potential of Schisandra chinensis extracts for treatment of hypertension. Introduction to: ‘Antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability' by Park. Hypertens Res. 35:892–893.
   PubMed Web of Science ®Google Scholar
• Chapple SJ, Siow RC, Mann GE. 2012. Crosstalk between Nrf2 and the proteasome: therapeutic potential of Nrf2 inducers in vascular disease and aging. Int J Biochem Cell Biol. 44:1315–1320.
   PubMed Web of Science ®Google Scholar
• Chinese Pharmacopeia Commission. 2015. Pharmacopeia of the People’s Republic of China. Part 1. Beijing: China Medical Science Press; p. 66–67.
   Google Scholar
• Collins AR, Lyon CJ, Xia X, Liu JZ, Tangirala RK, Yin F, Boyadjian R, Bikineyeva A, Pratico D, Harrison DG, et al. 2009. Age-accelerated atherosclerosis correlates with failure to upregulate antioxidant genes. Circ Res. 104:e42–E54.
   PubMed Web of Science ®Google Scholar
• Davidson MH. 2007. Overview of prevention and treatment of atherosclerosis with lipid-altering therapy for pharmacy directors. Am J Manag Care. 13 Suppl 10:S260–S269.
   PubMed Web of Science ®Google Scholar
• Durrington PN, Mackness B, Mackness MI. 2001. Paraoxonase and atherosclerosis. Arterioscler Thromb Vasc Biol. 21:473–480.
   PubMed Web of Science ®Google Scholar
• Fan XS, Duan JA, Wang ZY, Yao YZ. 2009. On characteristic properties of TCM dose-effect relationship. China J Tradit Chinese Med Pharm. 24:270–274.
   Google Scholar
• Félétou M, Vanhoutte PM. 2006. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Hear Circ Physiol. 291:H985–H1002.
   PubMed Web of Science ®Google Scholar
• Fishbein MC, Fishbein GA. 2015. Arteriosclerosis: facts and fancy. Cardiovasc Pathol. 24:335–342.
   PubMed Web of Science ®Google Scholar
• Fu W-J, Lei T, Yin Z, Pan J-H, Chai Y-S, Xu X-Y, Yan Y-X, Wang Z-H, Ke J, Wu G, et al. 2017. Anti-atherosclerosis and cardio-protective effects of the Angong Niuhuang Pill on a high fat and vitamin D3 induced rodent model of atherosclerosis. J Ethnopharmacol. 195:118–126.
   PubMed Web of Science ®Google Scholar
• Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. 2003. Role of oxidative stress in atherosclerosis. Am J Cardiol. 91:7A–11A.
   PubMed Web of Science ®Google Scholar
• Jeong WS, Jun M, Kong AN. 2006. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal. 8:99–106.
   PubMed Web of Science ®Google Scholar
• Kang JS, Han MH, Kim GY, Kim CM, Kim BW, Hwang HJ, Hyun Y. 2014. Nrf2-mediated HO-1 induction contributes to antioxidant capacity of a Schisandrae Fructus ethanol extract in C2C12 myoblasts. Nutrients. 6:5667–5678.
   PubMed Web of Science ®Google Scholar
• Kong WJ, Wei J, Zuo ZY, Wang YM, Song DQ, You XF, Zhao LX, Pan HN, Jiang JD. 2008. Combination of simvastatin with berberine improves the lipid-lowering efficacy. Metab Clin Exp. 57:1029–1037.
   PubMed Web of Science ®Google Scholar
• Ling L, Liu HG, Chen M, Liu GP. 2016. Comparison of three methods for establishing rat models of atherosclerosis. Chinese J New Drugs. 25:1903–1908.
   Google Scholar
• Lin HS, Jenner AM, Ong CN, Huang SH, Whiteman M, Halliwell B. 2004. A high-throughput and sensitive methodology for the quantification of urinary 8-hydroxy-2-deoxyguanosine: measurement with gas chromatography-mass spectrometry after single solid-phase extraction. Biochem J. 380:541–548.
   PubMed Web of Science ®Google Scholar
• Li PC, Poon KT, Ko KM. 1996. Schisandra chinensis-dependent myocardial protective action of sheng-mai-san in rats. Am J Chin Med. 24:255–262.
   PubMed Web of Science ®Google Scholar
• Li Y, Yang G, Yang X, Wang W, Zhang J, He Y, Zhang W, Jing T, Lin R. 2016. Nicotinic acid inhibits NLRP3 inflammasome activation via SIRT1 in vascular endothelial cells. Int Immunopharmacol. 40:211–218.
   PubMed Web of Science ®Google Scholar
• Montecucco F, Mach F. 2009. Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis. Rheumatology. 48:11–22.
   PubMed Web of Science ®Google Scholar
• Morrow JD. 2005. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol. 25:279–286.
   PubMed Web of Science ®Google Scholar
• Napoli C, Triggiani M, Palumbo G, Condorelli M, Chiariello M, Ambrosio G. 1997. Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein. Basic Res Cardiol. 92:96–105.
   PubMed Web of Science ®Google Scholar
• Ni L, Yang X. 2012. Determination of schisandrin, deoxyschizandrin and γ-schisandrin in Shengmai Oral Liquid by HPLC. Chinese Traditional Patent Medicine. 34:872–875.
   Google Scholar
• Niu H, Wang W, Li J, Lei Y, Zhao Y, Yang W, Zhao C, Lin B, Song S, Wang S. 2017. A novel structural class of coumarin-chalcone fibrates as PPARα/γ agonists with potent antioxidant activities: design, synthesis, biological evaluation and molecular docking studies. Eur J Med Chem. 138:212–220.
   PubMed Web of Science ®Google Scholar
• Panossian A, Wikman G. 2008. Pharmacology of Schisandra chinensis Bail: an overview of Russian research and uses in medicine. J Ethnopharmacol. 118:183–212.
   PubMed Web of Science ®Google Scholar
• Park EJ, Chun JN, Kim SH, Kim CY, Lee HJ, Kim HK, Park JK, Lee SW, So I, Jeon J. 2012. Schisandrin B suppresses TGFβ1 signaling by inhibiting Smad2/3 and MAPK pathways. Biochem Pharmacol. 83:378–384.
   PubMed Web of Science ®Google Scholar
• Qian L, Ma L, Wu G, Yu Q, Lin H, Ying Q, Wen D, Gao C. 2017. G004, a synthetic sulfonylurea compound, exerts anti-atherosclerosis effects by targeting SIRT1 in ApoE−/− mice. Vascul Pharmacol. 89:49–57.
   PubMed Web of Science ®Google Scholar
• Savel J, Lafitte M, Pucheu Y, Pradeau V, Tabarin A, Couffinhal T. 2012. Very low levels of HDL cholesterol and atherosclerosis, a variable relationship-a review of LCAT deficiency. Vasc Heal Risk Manag. 8:357–361.
   PubMedGoogle Scholar
• Steinberg D. 1997. Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis. Circulation. 95:1062–1071.
   PubMed Web of Science ®Google Scholar
• Stephens JW, Khanolkar MP, Bain SC. 2009. The biological relevance and measurement of plasma markers of oxidative stress in diabetes and cardiovascular disease. Atherosclerosis. 202:321–329.
   PubMed Web of Science ®Google Scholar
• Sun JH, Liu X, Cong LX, Li H, Zhang CY, Chen JG, Wang CM. 2017. Metabolomics study of the therapeutic mechanism of Schisandra Chinensis lignans in diet-induced hyperlipidemia mice. Lipids Heal Dis. 16:145–158.
   PubMed Web of Science ®Google Scholar
• Tsukahara H. 2007. Biomarkers for oxidative stress: clinical application in pediatric medicine. Curr Med Chem. 14:339–351.
   PubMed Web of Science ®Google Scholar
• Wei SN, Su XY, Su GH. 2016. Anomaly of triglyceride metabolism in liver lead to NAFLD. Chinese J Biochem Mol Biol. 32:123–132.
   Google Scholar
• World Health Organization. 1993. Research guidelines for evaluating the safety and efficacy of herbal medicines manila: WHO Regional Office for the Western Pacific. Manila, Philippines: World Health Organization.
   Google Scholar
• Xu Y, Liu Z, Sun J, Pan Q, Sun F, Yan Z, Hu X. 2011. Schisandrin B prevents doxorubicin-induced chronic cardiotoxicity and enhances its anticancer activity in vivo. PLoS One. 6:e28335–e28362.
   PubMed Web of Science ®Google Scholar
• Yamawaki H, Haendeler J, Berk BC. 2003. Thioredoxin: a key regulator of cardiovascular homeostasis. Circ Res. 93:1029–1033.
   PubMed Web of Science ®Google Scholar
• Zhang J, Liang R, Wang L, Yan R, Hou R, Gao S, Yang B. 2013. Effects of an aqueous extract of Crataegus pinnatifida Bge. var. major N.E.Br. fruit on experimental atherosclerosis in rats. J Ethnopharmacol. 148:563–569.
   PubMed Web of Science ®Google Scholar
• Zhou H, Wu XY, Yuan YB, Qi XH. 2012. Comparison of methods for establishing a rat model of atherosclerosis using three-doses of vitamin D3 and atherogenic diet. Chinese J Arterioscler. 20:995–998.
   Google Scholar
• Zhou YG, Lan XH, Xiang LI. 2011. Establishment and evaluation of an atherosclerosis model in rats. Pharm J Chinese Peoples Lib Army. 27:399–403.
   Google Scholar
• Zhu JL, Xu KK, Zhang XM, Cao JH, Jia ZR, Yang RC, Ma CY, Chen C, Zhang TN, Yan ZY. 2016. Studies on the regulation of lipid metabolism and its mechanism of the iridoids rich fraction in Valeriana jatamansi Jones. Biomed Pharmacother. 84:1891–1898.
   PubMed Web of Science ®Google Scholar